Stock screener

CGON

Conviction 55HealthcareScan · Thu, Sep 24, 2026

CG Oncology, Inc. (CGON) closed at $68.76 (-6.27%) on Sep 24, 2026. Price is below its 50-day and above its 200-day moving average. RSI(14) 38, RS Rating 91, -14.8% from its 52-week high, +64.5% year to date. Sector: Healthcare · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES).

CGON$68.76-6.27%
ResistanceSupportVol 14Insider buyInsider sell
63 bars
Vol MA14 1.18M
Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24
CG Oncology, Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.cgoncology.com ↗
Price68.76
Change-6.27%
Gap-0.57%
Rel volume5.70×
Avg volume1.01M
Avg $ vol73.94M
SMA 2074.32
SMA 5074.19
SMA 20063.08
Price vs 50-7.31%
Price vs 200+9.00%
MA stackmixed
50/200 cross—
Supertrenddown · 80.21
RSI (14)38
MACD hist-0.33
MACD crossbear · 0d
Stoch %K / %D5 / 36
ADX (14)17
+DI / −DI21 / 28
RSI divergence—
MACD divergence—
ATR %4.96%
ADR %4.35%
52w high80.68
52w low36.48
From 52w high-14.77%
Above 52w low+88.49%
New 52w highNo
SqueezeOn · 3d
Bollinger width12.34%
%B-0.11
Donchian pos4.51%
Donchian high80.63
Donchian low68.20
AVWAP (52w high)74.69
vs AVWAP high-7.94%
AVWAP (52w low)59.22
vs AVWAP low+16.10%
OBV trendDown
Chaikin MF (20)-0.16
Today vs 20d5.70×
Avg vol (14d)1.18M
Avg vol (20d)1.01M
Avg $ vol (20d)73.94M
Market cap6.09B
RS Rating91 / 99
RS 3m (vs SPY)-10.09%
RS 6m (vs SPY)-12.33%
RS line new highNo
Trend template6/8
Technical rank47.1
1 week-9.07%
1 month-12.91%
3 months-5.60%
6 months+4.48%
1 year+87.36%
YTD+64.54%
P/E-37.86
P/B5.92
P/S—
P/FCF-46.01
EPS-2.08
Div yield—
ROE-15.64%
ROA-14.83%
Debt/Eq0.00
Current22.22
EV/EBITDA-32.10
Gross margin—
Net margin—
Rev growth254.70%
EPS growth-82.87%
Price target92.56
Target upside34.61%
Analyst ratingBuy
Institutional113.31%
Ent. value6.08B
Revenue1.16M
Net income-79.06M
Gross profit—
Free cash flow-132.48M
IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
ExchangeNasdaq
Shares out88.2M
Employees142
ListedThu, Jan 25, 2024
Free float55.61M
Float %68.9%
Short interest11.4M
Days to cover16.1d
Short volume53.0%
Squeeze score89 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.90 vs −$0.70
Last surprise-28.6% miss
Setup gradeC
Conviction55 / 100
Pattern quality—
Tech rank47.1 / 100
Group rank59 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance80.56
Support71.06
Days since event—
Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Recent news

Congress activity

Disclosed STOCK Act trades in CGON

All disclosures →
No recent disclosed trades by Congress in CGON. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in CGON · open-market 1 buy · 3 sells

InsiderSideShares
POST LEONARD E
Director · Common Stock · 2026-09-15
Exercise1K
POST LEONARD E
Director · Common Stock · 2026-09-15
Sell1K
POST LEONARD E
Director · Director Stock Option (right to buy) · 2026-09-15
Exercise1K
POST LEONARD E
Director · Common Stock · 2026-08-14
Exercise1K
POST LEONARD E
Director · Common Stock · 2026-08-14
Sell1K
POST LEONARD E
Director · Director Stock Option (right to buy) · 2026-08-14
Exercise1K
POST LEONARD E
Director · Common Stock · 2026-07-15
Exercise1K
POST LEONARD E
Director · Common Stock · 2026-07-15
Sell1K
POST LEONARD E
Director · Director Stock Option (right to buy) · 2026-07-15
Exercise1K
Liu Brian Guan-Chyun
Director · Common Stock · 2026-06-25
Buy371.08K

SEC filings

EDGAR filings in CGON · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.